These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37962780)

  • 1. A quality improvement study of the implementation and initial results of a pragmatic clinical decision support system in the community pharmacy setting.
    Bogaerts C; Schoenmaekers N; Haems M; Storme M; De Loof H
    Int J Clin Pharm; 2024 Feb; 46(1):141-149. PubMed ID: 37962780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a clinical decision support tool to assess the risk of QT drug-drug interactions in community pharmacies.
    Berger FA; van der Sijs H; van Gelder T; van den Bemt PMLA
    Ther Adv Drug Saf; 2021; 12():2042098621996098. PubMed ID: 33708374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation study of an intermediate medication review in Belgian community pharmacies.
    Lelubre M; Wuyts J; Maesschalck J; Duquet N; Foubert K; Hutsebaut C; Moullin J; De Wulf I; Boussery K; Foulon V; De Vriese C
    Res Social Adm Pharm; 2019 Jun; 15(6):710-723. PubMed ID: 30241873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing Inappropriate Drug Use in Older Patients by Use of Clinical Decision Support in Community Pharmacy: A Mixed-Methods Evaluation.
    Mulder-Wildemors LGM; Heringa M; Floor-Schreudering A; Jansen PAF; Bouvy ML
    Drugs Aging; 2020 Feb; 37(2):115-123. PubMed ID: 31782128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-drug interactions with risk of QT-prolongation. A epidemiological study in Belgian community pharmacies].
    Vandael E; De WuLf I; Foulon V
    J Pharm Belg; 2016 Dec; (4):14-23. PubMed ID: 30281244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-related problems identified during medication review before and after the introduction of a clinical decision support system.
    Verdoorn S; Kwint HF; Hoogland P; Gussekloo J; Bouvy ML
    J Clin Pharm Ther; 2018 Apr; 43(2):224-231. PubMed ID: 28971492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical evaluation of the drug-related problem management process in Swiss community pharmacies.
    Krähenbühl JM; Kremer B; Guignard B; Bugnon O
    Pharm World Sci; 2008 Dec; 30(6):777-86. PubMed ID: 18392732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing pharmacists' detection of prescribing errors: Comparison of on-ward and central pharmacy services.
    Lagreula J; Maes F; Wouters D; Quennery S; Dalleur O
    J Clin Pharm Ther; 2021 Jun; 46(3):738-743. PubMed ID: 33768608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007.
    Look KA; Mott DA; Leedham RK; Kreling DH; Hermansen-Kobulnicky CJ
    J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.
    Hines LE; Saverno KR; Warholak TL; Taylor A; Grizzle AJ; Murphy JE; Malone DC
    Res Social Adm Pharm; 2011 Dec; 7(4):359-68. PubMed ID: 21530417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of community pharmacists' engagement in pharmacy-delivered influenza vaccination: a mixed-methods study.
    Chadi A; Gabet M; Robitaille A; David PM
    Int J Pharm Pract; 2022 Jan; 30(1):36-44. PubMed ID: 34904643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
    Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
    Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective evaluation of preconception care opportunities in a chain community pharmacy setting.
    Roath ED; Bright DR; DiPietro Mager NA
    J Am Pharm Assoc (2003); 2021; 61(3):325-330. PubMed ID: 33583748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot study.
    Nielsen S; Picco L; Kowalski M; Sanfilippo P; Wood P; Larney S; Bruno R; Ritter A
    Res Social Adm Pharm; 2020 Dec; 16(12):1694-1701. PubMed ID: 32273255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium.
    Fraeyman J; Foulon V; Mehuys E; Boussery K; Saevels J; De Vriese C; Dalleur O; Housiaux M; Steurbaut S; Naegels M; De Meyer GR; De Loof H; Van Hal G; Van den Broucke S
    Res Social Adm Pharm; 2017; 13(1):98-108. PubMed ID: 26975932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' experience of a diabetes risk-assessment service and analytical quality control in community pharmacies - A focus-group study.
    Risøy AJ; Skeide Kjome RL; Svensberg K; Råheim M; Sølvik UØ
    Res Social Adm Pharm; 2021 Jul; 17(7):1259-1266. PubMed ID: 34155978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.